Evidence map›Paper›PMID 38984978›Full record

ArticleFunction (Oxford, England)2024

Electrophysiology of Human iPSC-derived Vascular Smooth Muscle Cells and Cell-autonomous Consequences of Cantú Syndrome Mutations.

Alex Hanson, Conor McClenaghan, Kuo-Chan Weng, Sarah Colijn, Amber N Stratman, Carmen M Halabi, Dorothy K Grange, Jonathan R Silva, Colin G Nichols

Abstract read
In one paragraph

Article in Function (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Bayliss-Starling Prize Lecture: KThe Journal of physiology · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Alex HansonCenter for the Investigation of Membrane Excitability Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA.
Conor McClenaghanCenter for the Investigation of Membrane Excitability Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA.
Kuo-Chan WengDepartment of Biomedical Engineering, Washington University in Saint Louis, St. Louis, MO 63110, USA.
Sarah ColijnCenter for the Investigation of Membrane Excitability Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA.
Amber N StratmanCenter for the Investigation of Membrane Excitability Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA.
Carmen M HalabiDepartment of Pediatrics, Washington University in St. Louis, St. Louis, MO 63130, USA.
Dorothy K GrangeDepartment of Pediatrics, Washington University in St. Louis, St. Louis, MO 63130, USA.
Jonathan R SilvaDepartment of Biomedical Engineering, Washington University in Saint Louis, St. Louis, MO 63110, USA.
Colin G NicholsCenter for the Investigation of Membrane Excitability Diseases, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0002-4929-2134

Funding

Tenancin-C as a major component of the fibrogenic nicheR01DK064005 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TAN, RODERICK JASON · 2003 to 2021
$5.1M
Pediatric Cardiovascular and Pulmonary Research Training Program.T32HL125241 · NHLBI · WASHINGTON UNIVERSITY · PI Juliane Bubeck Wardenburg, Kory J. Lavine · 2015 to 2026
$4.1M
Cardiovascular potassium channels: From molecular basis to disease therapeuticsR35HL171542 · NHLBI · WASHINGTON UNIVERSITY · PI Colin G Nichols · 2024 to 2026
$3.2M
Effect of Renal Nerves on Chronic Kidney DiseaseR01DK131991 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Roderick Jason Tan · 2022 to 2026
$2.6M
Endocytic Pathway Dysfunction in Dent DiseaseR01DK125049 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WEISZ, ORA A · 2020 to 2024
$2.3M
Electrical excitability in vascular smooth muscle: from rare disease to new paradigmsR00HL150277 · NHLBI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI MCCLENAGHAN, CONOR · 2022 to 2024
$747k
Vascular Extracellular Matrix in Arterial Development and DiseaseK08HL135400 · NHLBI · WASHINGTON UNIVERSITY · PI HALABI, CARMEN M. · 2017 to 2020
$613k
Clinical Trial Readiness for K channel inhibitors in Cantu SyndromeR21HD103347 · NICHD · WASHINGTON UNIVERSITY · PI GRANGE, DOROTHY KATHERINE, NICHOLS, COLIN G · 2020 to 2021
$433k
NHLBI NIH HHS K08 HL135400NHLBI NIH HHS R00 HL150277NHLBI NIH HHS R35 HL171542NHLBI NIH HHS T32 HL125241NICHD NIH HHS R21 HD103347NIDDK NIH HHS R01 DK064005NIDDK NIH HHS R01 DK125049NIDDK NIH HHS R01 DK131991NIH HHS R35 HL171542
6 · The paper itself

Abstract

Cantú syndrome (CS), a multisystem disease with a complex cardiovascular phenotype, is caused by gain-of-function (GoF) variants in the Kir6.1/SUR2 subunits of ATP-sensitive potassium (KATP) channels and is characterized by low systemic vascular resistance, as well as tortuous, dilated, vessels, and decreased pulse-wave velocity. Thus, CS vascular dysfunction is multifactorial, with both hypomyotonic and hyperelastic components. To dissect whether such complexities arise cell autonomously within vascular smooth muscle cells (VSMCs) or as secondary responses to the pathophysiological milieu, we assessed electrical properties and gene expression in human induced pluripotent stem cell-derived VSMCs (hiPSC-VSMCs), differentiated from control and CS patient-derived hiPSCs, and in native mouse control and CS VSMCs. Whole-cell voltage clamp of isolated aortic and mesenteric arterial VSMCs isolated from wild-type (WT) and Kir6.1[V65M] (CS) mice revealed no clear differences in voltage-gated K+ (Kv) or Ca2+ currents. Kv and Ca2+ currents were also not different between validated hiPSC-VSMCs differentiated from control and CS patient-derived hiPSCs. While pinacidil-sensitive KATP currents in control hiPSC-VSMCs were similar to those in WT mouse VSMCs, they were considerably larger in CS hiPSC-VSMCs. Under current-clamp conditions, CS hiPSC-VSMCs were also hyperpolarized, consistent with increased basal K conductance and providing an explanation for decreased tone and decreased vascular resistance in CS. Increased compliance was observed in isolated CS mouse aortae and was associated with increased elastin mRNA expression. This was consistent with higher levels of elastin mRNA in CS hiPSC-VSMCs and suggesting that the hyperelastic component of CS vasculopathy is a cell-autonomous consequence of vascular KATP GoF. The results show that hiPSC-VSMCs reiterate expression of the same major ion currents as primary VSMCs, validating the use of these cells to study vascular disease. Results in hiPSC-VSMCs derived from CS patient cells suggest that both the hypomyotonic and hyperelastic components of CS vasculopathy are cell-autonomous phenomena driven by KATP overactivity within VSMCs .

Indexed as

HypertrichosisInduced Pluripotent Stem CellsKATP ChannelsMuscle, Smooth, VascularMyocytes, Smooth MuscleAnimalsCardiomegalyCell DifferentiationHumansMiceMutationOsteochondrodysplasiasPatch-Clamp TechniquesSulfonylurea ReceptorsABCC9 protein, humanKATP ChannelsSulfonylurea ReceptorsuK-ATP-1 potassium channelABCC9BKblood pressureCantú syndromecardiac myocytecardiovascular systemCas9cell-autonomousCRISPRhiPSCI CaKATPKCNJ8Kir6.1KvLTCRT-PCRsmooth muscleSUR2systemic vascular resistancevascular compliancevascular tonevascular treevasculopathyV mVSMCwhole-cell patch clamp

Identifiers

PMID38984978
PMCPMC11388097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.